Vimarsana
Biggest News Aggregation in the World

Page 11 - Sny News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sny. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sny Today - Breaking & Trending Today

AlphaQ Advisors LLC Sells 729 Shares of Sanofi (NASDAQ:SNY) - Vimarsana News

AlphaQ Advisors LLC Sells 729 Shares of Sanofi (NASDAQ:SNY)

AlphaQ Advisors LLC reduced its holdings in Sanofi (NASDAQ:SNY – Free Report) by 9.2% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 7,187 shares of the company’s stock after selling 729 shares during the quarter. AlphaQ Advisors LLC’s holdings in Sanofi were […]

Source: wkrb13.com
Confetti Cleanup: DSNY clears 100,000 pounds of litter in Times Square by daybreak - Vimarsana News

Confetti Cleanup: DSNY clears 100,000 pounds of litter in Times Square by daybreak

Once the ball dropped in Times Square to ring in 2024, a colossal amount of confetti fell from the sky and landed on the street below.

Source: abc7ny.com
Sanofi (NASDAQ:SNY) Cut to Hold at StockNews.com - Vimarsana News

Sanofi (NASDAQ:SNY) Cut to Hold at StockNews.com

StockNews.com cut shares of Sanofi (NASDAQ:SNY – Free Report) from a buy rating to a hold rating in a report issued on Thursday morning. SNY has been the topic of several other reports. JPMorgan Chase & Co. lowered Sanofi from an overweight rating to a neutral rating in a research note on Tuesday, December 5th. […]

Source: wkrb13.com
Ritholtz Wealth Management Acquires 622 Shares of Sanofi (NASDAQ:SNY) - Vimarsana News

Ritholtz Wealth Management Acquires 622 Shares of Sanofi (NASDAQ:SNY)

Ritholtz Wealth Management increased its holdings in shares of Sanofi (NASDAQ:SNY – Free Report) by 2.0% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 32,001 shares of the company’s stock after acquiring an additional 622 shares during the quarter. Ritholtz Wealth Management’s […]

Sanofi Ends Drug Program After Late-Stage Trial in Lung Cancer Fails - Vimarsana News

Sanofi Ends Drug Program After Late-Stage Trial in Lung Cancer Fails

By Adria Calatayud Sanofi said it would end a clinical-development program for its tusamitamab ravtansine drug candidate after a late-stage trial in...